CD28 induces cell cycle progression by IL-2-independent down-regulation of p27(kip1) expression in human peripheral T lymphocytes

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 789-798

  Boonen, Ger J J C ^a   Van Dijk, Astrid M C ^a   Verdonck, Leo F ^a   Van Lier, René A W ^b   Rijksen, Gert ^a   Medema, René H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

CD28; Cell cycle; IL 2; P27(kip1); T lymphocyte

Indexed keywords

CD28 ANTIGEN; CYCLIN D3; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROTEIN P27;

ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; DOWN REGULATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033016465     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199903)29:03<789::aid-immu789>3.0.co;2-5     Document Type: Article

References (37)

1. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
2. Fraser, J. D., Irving, B. A., Crabtree, G. R. and Weiss, A., Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991. 251: 313-316.
3. Lindsten, T., June, C. H., Ledbetter, J. A., Stella, G. and Thompson, C. B., Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989. 244: 339-343.
4. L. Immunity 1995. 3: 87-98.
5. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A., CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994. 1: 405-413.
6. de Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P. and Ceuppens, J. L., Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 1993. 23: 3120-3125.
7. Toyooka, K., Maruo, S., Iwahori, T., Yamamoto, N., Tai, X.-G., Abe, Y., Takahama, R. Y., Murakami, M., Uede, T., Hamaoka, T. and Fujiwara, H., CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism. Int. Immunol. 1996. 8: 159-169.
8. Schwartz, R. H., Models of T cell anergy: is there a common molecular mechanisms. J. Exp. Med. 1996. 184: 1-8.
9. Sherr, C. J., D-type cyclins. Trends Biochem. Sci. 1995. 20: 187-190.
10. Sutherland, R. L., Watts, C. K. W. and Musgrove, E. A., Cyclin gene expression and growth control in normal and neoplastic human breast epithelium. J. Steroid. Biochem. Mol. Biol. 1993. 47: 99-106.
11. Tam, S. W., Theodoras, A. M., Shay, J. W., Draetta, G. F. and Pagano, M., Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene 1994. 9: 2663-2674.
12. Turner, J. M., IL-2-dependent induction of G1 cyclins in primary T cells is not blocked by rapamycin or cyclosporin A. Int. Immunol. 1993. 5: 1199-1209.
13. kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994. 372: 571-573.
14. Firpo, E. J., Koff, A., Solomon, M. J. and Roberts, J. M., Inactivation of a cdk2 inhibitor during interleukin-2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 1993. 14: 4889-4901.
15. Abraham, R. T., Karnitz, L. M., Burns, L. A. and Brunn, G. J., Proximal signals and the control of S-phase entry in interleukin-2-stimulated T lymphocytes. In Gupta, V. S. et al. (Eds.) Mechanisms of Lymphocyte Activation and Immune Regulation. Plenum Press, New York 1994, pp 197-210.
16. van Dijk, A. M. C., Otten, H. G., Vercauteren, S. M., Kessler, F. L., de Boer, M., Verdonck, L. F. and de Gast, G. C., Human B7-1 is more efficient in providing co-stimulation for alloantigen-specific T cells. Eur. J. Immunol. 1996. 26: 2275-2278.
17. Schreiber, S. L. and Crabtree, G. R., The mechanism of action of cyclosporin A and FK506. Immunol. Today 1992. 13: 136-142.
18. Modiano, J. F., Domenico, J., Szepesi, A., Lucas, J. J. and Gelfand, E. W., Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases cdk4 and cdk2 in human T cells. J. Biol. Chem. 1994. 269: 32972-32978.
19. Lai, J.-H. and Tan, T.-H., CD28 signaling causes a sustained down-regulation of I(greek small letter script kappa)Bα which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 1994. 269: 30077-30080.
20. Pai, S.-Y., Calvo, V., Wood, M. and Bierer, B. E., Cross-linking CD28 leads to activation of 70-kDa S6 kinase. Eur. J. Immunol. 1994. 24: 2364-2368.
21. Smith Shapiro, V., Truitt, K. E., Imboden, J. B. and Weiss, A., CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promotor through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 1997. 17: 4051-4058.
22. Bloemema, E., van Oers, R. H. J., Weinreich, S., Stilma-Meinesz, A. P., Schellekens, P. T. A. and van Lier, R. A. W., The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro. Eur. J. Immunol. 1989. 19: 943-946.
23. Anastassiou, E. D., Paliogianni, F., Balow, J. P., Yamada, H. and Boumpas, D. T., Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J. Immunol. 1992. 148: 2845-2852.
24. Krammer, G. M., The adenylate cyclase cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 1988. 9: 222-229.
25. Chen, D. and Rothenberg, E. V., Interleukin-2 transcription factors as molecular targets of cAMP inhibition:delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 1994. 179: 931-942.
26. Radvanyi, L. G., Shi, Y., Mills, G. B. and Miller, R. G., Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis. Cell Immunol. 1996. 170: 260-273.
27. Lalli, E., Sassone-Corsi, P. and Ceredig, R., Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. EMBO J. 1996. 15: 528-537.
28. Skalhegg, B. S., Rasmussen, A. M., Tasken, K., Hansson, V., Jahnsen, T. and Lea, T., Cyclic AMP sensitive signaling by the CD28 marker requires concomitant stimulation by the T cell antigen receptor (TCR/CD3) complex. Scand. J. Immunol. 1994. 40: 201-208.
29. Bartik, M. M., Bauman, G. P., Brooks, W. H. and Roszman, T. L., Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell Immunol. 1994. 158: 116-130.
30. Dumont, F. J. and Su, Q., Mechanisms of action of the immunosuppressant rapamycin. Life Sci. 1996. 58: 373-395.
31. cdc2 kinase activation in T lymphocytes. J. Biol. Chem. 1993. 268: 22737-22745.
32. Bierer, B. E., Schreiber, S. L. and Burakoff, S. J., The effect of the immunosuppressant FK506 on alternate pathways of T cell activation. Eur. J. Immunol. 1991. 21: 439-445.
33. Hsueh, Y.-P., Liang, H.-E., Ng, S.-Y. and Lai, M.-Z., CD28-costimulation activates cyclic AMP-responsive element binding protein in T lymphocytes. J. Immunol. 1997. 158: 85-93.
34. Bird, J. J., Brown, D. R., Mullen, A. C., Moskowitz, N. H., Mahowald, M. A., Sider, J. R., Gajewski, T. F., Wang, C.-R. and Reiner, S. L., Helper T cell differentiation is controlled by the cell cycle. Immunity 1998. 9: 229-237.
35. Khoruts, A., Mondino, A., Pape, K. A., Reiner, S. L. and Jenkins, M. K., A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin-2-independent mechanism. J. Exp. Med. 1998. 187: 225-236.
36. Sperling, A. I., Auger, J. A., Ehst, B. D., Rulifson, I. C., Thompson, C. B. and Bluestone, J. A., CD28/B7 interactions deliver a unique signal to naive T cells that regulates the survival but not early proliferation. J. Immunol. 1996. 157: 3903-3917.
37. Medema, R. H., Klompmaker, R., Smits, V. A. J. and Rijksen, G., P21 waf can block cells at two points in the cell cycle, but does not interfere with processive DNA replication or stress activated kinases. Oncogene 1998. 16: 431-441.